Related references
Note: Only part of the references are listed.Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes
Teresa Vanessa Fiorentino et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease
Eugenio Barone et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis
Matteo Tardelli et al.
HEPATOLOGY (2020)
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
Hui Deng et al.
ACTA PHARMACEUTICA SINICA B (2020)
Vildagliptin reduces myocardial ischemia-induced arrhythmogenesis via modulating inflammatory responses and promoting expression of genes regulating mitochondrial biogenesis in rats with type-II diabetes
Qin Yang et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2020)
Trelagliptin succinate: DPP-4 inhibitor to improve insulin resistance in adipocytes
Zhenhua Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Omarigliptin decreases inflammation and insulin resistance in a pleiotropic manner in patients with type 2 diabetes
Sachiko Hattori
DIABETOLOGY & METABOLIC SYNDROME (2020)
The Lipolysome-A Highly Complex and Dynamic Protein Network Orchestrating Cytoplasmic Triacylglycerol Degradation
Peter Hofer et al.
METABOLITES (2020)
Attenuation of Free Fatty Acid (FFA)-Induced Skeletal Muscle Cell Insulin Resistance by Resveratrol is Linked to Activation of AMPK and Inhibition of mTOR and p70 S6K
Danja J. Den Hartogh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Human proline specific peptidases: A comprehensive analysis
Yakov E. Dunaevsky et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2020)
Conformational gating, dynamics and allostery in human monoacylglycerol lipase
Sergiy Tyukhtenko et al.
SCIENTIFIC REPORTS (2020)
Inhibition of monoglyceride lipase by proton pump inhibitors: investigation using docking and in vitro experiments
Lina A. Dahabiyeh et al.
PHARMACOLOGICAL REPORTS (2020)
The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
Konstantinos Makrilakis
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity
Habib Yaribeygi et al.
LIFE SCIENCES (2019)
Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes
Amelie I. S. Sobczak et al.
NUTRIENTS (2019)
Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
Aida Habib et al.
GUT (2019)
Cerebroprotective activity of metformin, gosogliptin, citicoline and a novel GPR119 agonist in cerebral ischemia under experimental diabetes mellitus
I. N. Tyurenkov et al.
Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova (2018)
Critical role of Dipeptidyl Peptidase IV: A therapeutic target for cancer & diabetes
Priyankar Paira et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)
Structural Dynamics of DPP-4 and Its Influence on the Projection of Bioactive Ligands
Simone Queiroz Pantaleao et al.
MOLECULES (2018)
Dipeptidyl-Peptidase 4 Inhibitor Sitagliptin Ameliorates Hepatic Insulin Resistance by Modulating Inflammation and Autophagy in ob/ob Mice
Wenbin Zheng et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
ANALYSIS OF CRYSTAL STRUCTURES OF DIPEPTIDYL PEPTIDASE 4 (DPP 4) CO-CRYSTALLIZED WITH DIVERSE INHIBITORS
Jagatkumar Upadhyay et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH (2018)
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)
Carlotta Granchi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Cytosolic lipolysis and lipophagy: two sides of the same coin
Rudolf Zechner et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling
Gernot F. Grabner et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Involvement of insulin resistance in Dgalactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin
Sara Kenawy et al.
PLOS ONE (2017)
Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease
Ioannis Akoumianakis et al.
VASCULAR PHARMACOLOGY (2017)
Monoglyceride lipase: Structure and inhibitors
Laura Scalvini et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2016)
Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes Role of dipeptidyl peptidase-IV inhibition
Maria Rosaria Rizzo et al.
DIABETES CARE (2012)
Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution
Celine Schalk-Hihi et al.
PROTEIN SCIENCE (2011)
Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus
Chrysi Koliaki et al.
Diabetes Therapy (2011)
Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm
GS Wu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
Share Paper
